title: deltaN-p73 is a transcriptional target of the PML/RARalpha oncogene in myeloid differentiation.
authors: S
authors: S
authors: Mainardi
authors: A
authors: A
authors: Pelosi
authors: E
authors: E
authors: Palescandolo
authors: R
authors: R
authors: Riccioni
authors: G
authors: G
authors: Fontemaggi
authors: D
authors: D
authors: Diverio
authors: U
authors: U
authors: Testa
authors: A
authors: A
authors: Sacchi
authors: F
authors: F
authors: Grignani
authors: F
authors: F
authors: Lo-Coco
authors: M
authors: M
authors: Levrero
authors: G
authors: G
authors: Blandino
authors: M G
authors: MG
authors: Rizzo
mesh_terms: D001483:Base Sequence; D045744:Cell Line, Tumor; D004268:DNA-Binding Proteins / Q000235:genetics*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D008969:Molecular Sequence Data; D038042:Myelopoiesis / Q000235:genetics*; D009687:Nuclear Proteins / Q000235:genetics*; D015514:Oncogene Proteins, Fusion / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D011401:Promoter Regions, Genetic; D014158:Transcription, Genetic; D014212:Tretinoin / Q000494:pharmacology; D025521:Tumor Suppressor Proteins / Q000235:genetics*
chemical_list: D004268:DNA-Binding Proteins; D009687:Nuclear Proteins; D015514:Oncogene Proteins, Fusion; D025521:Tumor Suppressor Proteins; C093476:promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein; D014212:Tretinoin